Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Japan Long-term Safety for Tiotropium Plus Olodaterol
- Status
- COMPLETED
- Phase
- PHASE3
Bioavailability of 3 Different Formulations of BI 207127 in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.
- Status
- COMPLETED
- Phase
- PHASE3
Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients
- Status
- COMPLETED
- Phase
- PHASE3
BIBW 2992 (Afatinib) and Vinorelbine
- Status
- TERMINATED
- Phase
- PHASE2
This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease
- Status
- COMPLETED
- Phase
- N/A
Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPD
- Status
- COMPLETED
- Phase
- PHASE3
Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
Single Rising Dose Study (Intravenous Infusion and Subcutaneous Injection) of BI 655064 in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses
- Status
- COMPLETED
- Phase
- PHASE1
Follow on Study From RE-ALIGN
- Status
- TERMINATED
- Phase
- PHASE2
Pharmacokinetics and Safety Study of BI 695501 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Exposure of BI 409306 in Cerebrospinal Fluid (CSF) Relative to Plasma as Well as to Evaluation of the Effect of Different Doses of BI 409306 on the cGMP (Cyclic Guanosine Monophosphate) Levels in CSF in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE4